Indoco Remedies Limited (INDOCO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.162x

Based on the latest financial reports, Indoco Remedies Limited (INDOCO) has a cash flow conversion efficiency ratio of 0.162x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.58 Billion ≈ $17.06 Million USD) by net assets (Rs9.74 Billion ≈ $105.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Indoco Remedies Limited (INDOCO) balance sheet quality index to measure how much of total assets are equity-financed.

Indoco Remedies Limited - Cash Flow Conversion Efficiency Trend (2004–2026)

This chart illustrates how Indoco Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Indoco Remedies Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Indoco Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indoco Remedies Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Arad Investment & Industrial Development Ltd
TA:ARAD
0.124x
Pennar Industries Limited
NSE:PENIND
0.108x
Fossil Group Inc
NASDAQ:FOSL
-0.262x
Baazar Style Retail Limited
NSE:STYLEBAAZA
0.240x
Sizzle Acquisition Corp. II - Class A ordinary shares
NASDAQ:SZZL
0.000x
Live Oak Acquisition Corp. V Class A Ordinary Shares
NASDAQ:LOKV
-0.003x
Jasuindo Tiga Perkasa Tbk
JK:JTPE
-0.046x
Shanghai Lisheng Racing Co Ltd
SHE:002858
0.016x

Annual Cash Flow Conversion Efficiency for Indoco Remedies Limited (2004–2026)

The table below shows the annual cash flow conversion efficiency of Indoco Remedies Limited from 2004 to 2026. For the full company profile with market capitalisation and key ratios, see Indoco Remedies Limited (INDOCO) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs9.32 Billion
≈ $100.81 Million
Rs324.30 Million
≈ $3.51 Million
0.035x +27.04%
2025-03-31 Rs10.18 Billion
≈ $110.13 Million
Rs278.90 Million
≈ $3.02 Million
0.027x -80.43%
2024-03-31 Rs11.10 Billion
≈ $120.10 Million
Rs1.55 Billion
≈ $16.80 Million
0.140x -19.54%
2023-03-31 Rs10.28 Billion
≈ $111.20 Million
Rs1.79 Billion
≈ $19.34 Million
0.174x -9.50%
2022-03-31 Rs9.05 Billion
≈ $97.83 Million
Rs1.74 Billion
≈ $18.80 Million
0.192x +79.71%
2021-03-31 Rs7.69 Billion
≈ $83.16 Million
Rs822.22 Million
≈ $8.89 Million
0.107x -40.85%
2020-03-31 Rs6.80 Billion
≈ $73.49 Million
Rs1.23 Billion
≈ $13.29 Million
0.181x -9.61%
2019-03-31 Rs6.61 Billion
≈ $71.44 Million
Rs1.32 Billion
≈ $14.29 Million
0.200x +10.00%
2018-03-31 Rs6.75 Billion
≈ $73.00 Million
Rs1.23 Billion
≈ $13.27 Million
0.182x +33.64%
2017-03-31 Rs6.52 Billion
≈ $70.46 Million
Rs886.40 Million
≈ $9.59 Million
0.136x -29.86%
2016-03-31 Rs5.84 Billion
≈ $63.19 Million
Rs1.13 Billion
≈ $12.26 Million
0.194x -8.10%
2015-03-31 Rs5.19 Billion
≈ $56.11 Million
Rs1.09 Billion
≈ $11.84 Million
0.211x -2.30%
2014-03-31 Rs4.57 Billion
≈ $49.47 Million
Rs988.09 Million
≈ $10.69 Million
0.216x +29.87%
2013-03-31 Rs4.14 Billion
≈ $44.78 Million
Rs688.69 Million
≈ $7.45 Million
0.166x +8.53%
2012-03-31 Rs3.85 Billion
≈ $41.61 Million
Rs589.71 Million
≈ $6.38 Million
0.153x +27.38%
2011-03-31 Rs3.50 Billion
≈ $37.87 Million
Rs421.36 Million
≈ $4.56 Million
0.120x -21.91%
2010-03-31 Rs3.11 Billion
≈ $33.58 Million
Rs478.40 Million
≈ $5.17 Million
0.154x +13.60%
2009-03-31 Rs2.78 Billion
≈ $30.11 Million
Rs377.64 Million
≈ $4.08 Million
0.136x +30.76%
2008-03-31 Rs2.54 Billion
≈ $27.50 Million
Rs263.71 Million
≈ $2.85 Million
0.104x +185.15%
2007-03-31 Rs2.33 Billion
≈ $25.20 Million
Rs84.76 Million
≈ $916.63K
0.036x -80.49%
2006-03-31 Rs1.98 Billion
≈ $21.45 Million
Rs369.86 Million
≈ $4.00 Million
0.186x +438.09%
2005-03-31 Rs1.75 Billion
≈ $18.96 Million
Rs60.74 Million
≈ $656.92K
0.035x -81.85%
2004-03-31 Rs880.11 Million
≈ $9.52 Million
Rs168.02 Million
≈ $1.82 Million
0.191x --

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic
Market Cap
$245.06 Million
Rs22.66 Billion INR
Market Cap Rank
#15661 Global
#810 in India
Share Price
Rs245.84
Change (1 day)
+0.53%
52-Week Range
Rs164.00 - Rs324.50
All Time High
Rs511.66
About

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more